Business Description
NextCure is a clinical-stage biotech company founded in 2015 and based in Beltsville, Maryland, focused on developing new treatments for cancer and other serious diseases. Its pipeline includes several experimental therapies targeting tumor cells, immune system pathways, and conditions such as Alzheimer's disease, osteoarthritis, and leukemia. Key programs include antibody-drug conjugates and fusion proteins designed to help the immune system fight disease more effectively.
